Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity

✍ Scribed by Kim, K-p; Jang, G; Hong, Y S; Lim, H-S; Bae, K-s; Kim, H-S; Lee, S S; Shin, J-G; Lee, J-L; Ryu, M-H

• Book ID: 109838792
• Publisher: Nature Publishing Group
• Year: 2011
• Tongue: English
• Weight: 414 KB
• Volume: 104
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/bjc.2011.17